Abemaciclib Approved by FDA for Advanced or Metastatic Breast Cancer

| October 26, 2017 | 0 Comments
Abemaciclib Approved by FDA for Advanced or Metastatic Breast Cancer

FDA approved abemaciclib (Verzenio™) for the treatment of some people with advanced or metastatic HR-positive, HER2-negative breast cancer whose disease has progressed after treatment with hormone therapy.
See Original Article

Category: Recent News

About the Author ()

Leave a Reply